TUMORI JOURNAL, cilt.91, sa.4, ss.302-308, 2005 (SCI-Expanded, Scopus)
Aims and background: We evaluated the prognostic value of p53 protein, DNA content and S-phase fraction in patients with adenocarcinoma of the stomach or the gastroesophageal junction treated with adjuvant etoposide, doxorubicin and cisplatin.